EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use

Anita Hokken-Koelega, Alexandra Keller, Viatcheslav Rakov, Stefan Kipper, Jovanna Dahlgren

ISRN Endocrinology · 2011

DOI: 10.5402/2011/803948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Endocrinology, 2011. Verfasst von Anita Hokken-Koelega und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Division of Endocrinology, Sophia Children's Hospital/Erasmus University Medical Centre, 3015 GJ Rotterdam, The Netherland…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Novo Nordisk.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this 12-week open-label, uncontrolled study, patients ( n = 85 ; mean [SD] age 11.2 [3.95] years) were trained to use an injection device with an automatic needle insertion accessory (NordiFlex/NordiFlex PenMate: Novo Nordisk A/S, Bagsvaerd, Denmark) for growth hormone (GH) injection. The opinions of patients and the physicians/nurses who trained patients on device were recorded by questionnaire. Most (88.4%) patients reported that the device was “very easy/easy" to use. The majority (82.4%) of patients were “very satisfied/satisfied" with the device and 64% wished to continue its use. Device training instructions were reported as “very easy/easy" by 96.1% of physicians/nurses, and 65.8% of participants could use the device after ≤10-minute training. In this study, NordiFlex PenMate was well accepted by patients and medical staff. Patients had a high opinion of the device and over half wished to continue its use. High patient acceptance may facilitate treatment adherence optimizing treatment outcomes.

Autor:innen und Institutionen

  • Department of Paediatrics, Division of Endocrinology, Sophia Children's Hospital/Erasmus University Medical Centre, 3015 GJ Rotterdam, The Netherlands.

Förderung

  • Novo Nordisk

Zitieren

APA

Hokken-Koelega, A., Keller, A., Rakov, V., Kipper, S., & Dahlgren, J. (2011). Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use. ISRN Endocrinology. https://doi.org/10.5402/2011/803948

Vancouver

Hokken-Koelega A, Keller A, Rakov V, Kipper S, Dahlgren J. Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use. ISRN Endocrinology. 2011. doi:10.5402/2011/803948

BibTeX
@article{HokkenKoelega2011,
  author = {Hokken-Koelega, Anita and Keller, Alexandra and Rakov, Viatcheslav and Kipper, Stefan and Dahlgren, Jovanna},
  title = {Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use},
  journal = {ISRN Endocrinology},
  year = {2011},
  doi = {10.5402/2011/803948}
}
Kostenlos starten →